9,640€
-1,37%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid:
Ask:
Echtzeit-Chart der Astellas Pharma Inc. Aktie
Börsenkurse Astellas Pharma Inc.
| Börse Stuttgart | - | - | - | - | 9,640€ | -1,37% |
| Tradegate | - | - | - | - | 9,622€ | -0,62% |
| Lang & Schwarz | - | - | - | - | 9,635€ | -0,76% |
| Echtzeit Euro | - | - | - | - | 9,770€ | 0,10% |
| Börse Frankfurt | - | - | - | - | 9,623€ | 2,18% |
| gettex | - | - | - | - | 9,671€ | -0,48% |
Profil der Astellas Pharma Inc. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.